摘要
目的:探讨舒利迭治疗支气管哮喘的临床效果。方法:收治支气管哮喘患者63例,随机分成对照组30例和观察组33例,β2-受体兴奋剂、碱茶类药物、抗生素、祛痰剂,进行抗炎、平喘、解痉挛治疗等常规治疗,观察组在对照组的基础上给予舒利迭吸入,1～2吸/次,2次/日,均治疗2周。结果:经过治疗,对照组显效9例,显效率30.0%,有效10例,有效率33.3%,无效11例,无效率36.7%,总有效率63.3%。治疗组显效14例,显效率42.4%,有效14例,有效率42.4%,无效5例,无效率15.1%,总有效率84.9%。两组比较有显著性差异(P<0.05)。结论:舒利迭治疗支气管哮喘的临床疗效确切。
Objective：To investigate the treatment of bronchial asthma Seretide clinical results.Methods：The hospital in January 2010-May 2011 63 patients with bronchial asthma treatment were randomly divided into a control group of 30 patients,observed 33 patients,β2-agonist,alkaline tea drugs,antibiotics,expectorant agents,anti-inflammatory,asthma,spasm of the solution treatment and other conventional treatment,observation group were given on the basis of Seretide inhalation,1 or 2 suction/times,2 times/d,were treated for 2 weeks.Results：After treatment,effective in the control group,9 cases markedly effective rate was 30.0%,10 cases,the effective rate was 33.3%,11 cases,ineffective rate was 36.7%,the total effective rate was 63.3%;treatment group 14 cases,effective rate was 42.4%,effective 14 cases,the effective rate was 42.4%,5 cases ineffective,ineffective rate was 15.1%,the total effective rate was 84.9%;two groups was significant difference（P〈0.05）.Conclusion：Seretide treatment of bronchial asthma clinical efficacy,it is worth promoting.
